Daniel Pinsky I Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 877 South Street, Clinical Support Options Suite 200, Pittsfiled, MA 01201 Phone: 413-236-5656 |
News Archive
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries.
New research by the charity Action on Sugar suggests that consumers are being misled into believing that honey and syrups are a healthy alternative to sugar.
A meta-analysis highlights the consistent observational finding that patients with myocardial infarction who receive blood transfusions are at high risk for dying.
› Verified 5 days ago